Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting
Clinical trial NCT02499627 · TERMINATED
Trial details
- NCT number
- NCT02499627
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-23
- Primary completion
- 2019-09-13
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.